aTyr Pharma, Inc. (ATYR)

0.8492 +0.01 (+0.99%) USD  |  NASDAQ  |  Apr 15, 16:00
0.8492 0.00 (0.00%) After-Hours: 20:00
More

aTyr Pharma Research and Development Expense (Annual) : 60.22M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for ATYR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Liquidia Corp. 38.45M
Agenus, Inc. 79.34M
Curis, Inc. 28.25M
Plus Therapeutics, Inc. 8.379M
Windtree Therapeutics, Inc. 16.19M